What is the recommended dose of Vitamin K (Vitamin K) for a term newborn?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: May 8, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

From the Guidelines

The recommended vitamin K dose for term newborns is a single intramuscular injection of 1 mg of vitamin K1 (phytonadione) administered shortly after birth, typically within the first 6 hours of life. This injection is usually given in the anterolateral aspect of the thigh. For parents who decline the injection, an oral regimen can be offered consisting of 2 mg oral vitamin K at birth, followed by 2 mg at 1-2 weeks of age, and a final 2 mg at 4-6 weeks of age. However, the oral regimen is less reliable in preventing late vitamin K deficiency bleeding.

Key Points

  • Vitamin K is essential for newborns because they are born with low vitamin K levels and limited gut bacteria to produce it naturally.
  • Without supplementation, newborns are at risk for vitamin K deficiency bleeding (VKDB), which can cause serious internal bleeding, including intracranial hemorrhage.
  • Breast milk contains low levels of vitamin K, making supplementation particularly important for breastfed infants.
  • The 1 mg dose has been shown to be safe and effective in preventing this potentially life-threatening condition, as supported by the most recent guidelines 1.

Administration

  • The intramuscular injection is the preferred route of administration due to its higher efficacy and reliability compared to oral supplementation.
  • The oral regimen may be considered for parents who decline the injection, but it requires careful adherence to the recommended dosing schedule.

Evidence

  • The recommended dose of 1 mg of vitamin K1 is based on the most recent and highest quality study available 1, which provides strong evidence for its safety and efficacy in preventing VKDB.
  • Other studies, such as 1, 1, 1, and 1, also support the importance of vitamin K supplementation in newborns, but the most recent guideline 1 takes precedence in informing clinical practice.

From the FDA Drug Label

The American Academy of Pediatrics recommends that vitamin K1 be given to the newborn. A single intramuscular dose of Vitamin K1 Injection 0. 5 to 1 mg within one hour of birth is recommended. The recommended Vitamin K dose for a term newborn is 0.5 to 1 mg given intramuscularly within one hour of birth for prophylaxis of hemorrhagic disease of the newborn 2.

From the Research

Vitamin K Dose for Term Newborns

  • The recommended dose of vitamin K for term newborns is 0.5 mg to 1.0 mg, administered intramuscularly (IM) at birth 3.
  • This dose is effective in preventing vitamin K deficiency bleeding (VKDB) in term newborns 4, 5, 3.
  • Oral vitamin K administration is also an option, but it requires multiple doses and has a lower efficacy compared to IM administration 5, 3.
  • The Canadian Paediatric Society and the College of Family Physicians of Canada recommend routine IM administration of a single dose of vitamin K at 0.5 mg to 1.0 mg to all newborns 3.
  • For parents who decline IM vitamin K, oral vitamin K (2.0 mg at birth, repeated at 2 to 4 and 6 to 8 weeks of age) can be administered, but healthcare providers should inform them of the increased risk of VKDB with this regimen 3.

Comparison of Different Doses

  • A study comparing 0.5 mg and 1 mg of vitamin K in premature infants found that both doses were effective in preventing hemorrhagic disease of the newborn, but 0.5 mg may be more than adequate 6.
  • The same study suggested that 0.3 mg/kg may be used for babies with birth weights below 1000 g 6.

Administration Routes

  • Intramuscular administration is the most effective route for vitamin K prophylaxis in term newborns 4, 5, 3.
  • Oral administration is an alternative, but it requires multiple doses and has a lower efficacy compared to IM administration 5, 3.
  • Intravenous administration is not recommended as a routine method for vitamin K prophylaxis in term newborns 3.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Guidelines for vitamin K prophylaxis in newborns.

Paediatrics & child health, 2018

Research

Vitamin K prophylaxis for premature infants: 1 mg versus 0.5 mg.

American journal of perinatology, 2003

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.